wiley 3/3

[MumboJumbo]

1) Combined action of C60 fullerene with dimethyl-N-(benzoyl)amidophosphate or dimethyl-N-(phenylsulfonyl)amidophosphate on leukemia L1210 cells in silico and in vitro
I. I. Grynyuk1,*, S. V. Prylutska1, D. V. Franskevych1, V. A. Trush1, T. Y. Sliva1, M. S. Slobodyanik1, V. V. Hurmach1, Y. I. Prylutskyy1, O. P. Matyshevska1 andU. Ritter
Physics and Chemistry of Nanostructures and Nanobiotechnology
Volume 47, Issue 2-3, pages 98–104, March 2016

DOI:

http://dx.doi.org/10.1002/mawe.201600471

2) Interaction of C60 fullerene complexed to cisplatin with model bilipid membranes and its uptake by HeLa cells
A. Bychko1, V. Sokolova2, S. Prylutska2,*, K. Bogutska2, V. Rybalchenko1, M. Evstigneev3, Y. Prylutskyy1, M. Epple2, U. Ritter4 andP. Scharff
Physics and Chemistry of Nanostructures and Nanobiotechnology
Volume 47, Issue 2-3, pages 105–111, March 2016

DOI:

http://dx.doi.org/10.1002/mawe.201600474

3) Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor
Lazaar AL1, Yang L2, Boardley RL3, Goyal NS1, Robertson J3, Baldwin SJ3, Newby DE4, Wilkinson IB2, Tal-Singer R1, Mayer RJ1, Cheriyan J
Br J Clin Pharmacol. 2015 Dec 1.

DOI:

http://dx.doi.org/10.1111/bcp.12855

@}->--

[Inte]